Reduction of LE (%) · treatment of arm lymphoedema
It is very uncertain whether vascularised lymph node transfer changes reduction of LE (%) compared with standard care (very low certainty).
1 finding from 1 review
Number of infections per year · treatment of arm lymphoedema
It is very uncertain whether vascularised lymph node transfer changes number of infections per year compared with standard care (very low certainty).
1 finding from 1 review
Pain at 6 months or more; all doses Assessed by change from baseline, using a 0‐ to 100‐mm VAS, where higher scores indicate more pain) · treatment of arm lymphoedema
It is very uncertain whether vascularised lymph node transfer changes pain score (1‐10; where 1 = no pain; 10 = extreme pain) compared with standard care (very low certainty).
1 finding from 1 review
Heaviness score (1‐10; where 1 = no heaviness; 10 = extreme heaviness) · treatment of arm lymphoedema
It is very uncertain whether vascularised lymph node transfer changes heaviness score (1‐10; where 1 = no heaviness; 10 = extreme heaviness) compared with standard care (very low certainty).
1 finding from 1 review
BASFI (score from 0 to 10, 0=excellent, 10=poor function) · treatment of arm lymphoedema
It is very uncertain whether vascularised lymph node transfer changes function score (1‐10; where 1 = good function; 10 = poor function) compared with standard care (very low certainty).
1 finding from 1 review
Intervention not reported
Time to event (Lymphoedema) volumetry · patients at risk for secondary upper limb lymphoedema after breast cancer treatment
It is very uncertain whether the intervention changes time to event (Lymphoedema) volumetry (very low certainty).
1 finding from 1 review
Shoulder range of motion for abduction ‐ medium term · patients at risk for secondary upper limb lymphoedema after breast cancer treatment
1 finding from 1 review
Shoulder range of motion for forward flexion ‐ short term · patients at risk for secondary upper limb lymphoedema after breast cancer treatment
1 finding from 1 review
Shoulder range of motion for forward flexion ‐ medium term · patients at risk for secondary upper limb lymphoedema after breast cancer treatment
1 finding from 1 review
Shoulder range of motion for external rotation ‐ medium term · patients at risk for secondary upper limb lymphoedema after breast cancer treatment
1 finding from 1 review
Shoulder range of motion for internal rotation ‐ medium term · patients at risk for secondary upper limb lymphoedema after breast cancer treatment
1 finding from 1 review
Intervention not reported
Lymphoedema Volumetry · patients at risk for secondary upper limb lymphoedema after breast cancer treatment
The intervention showed no clear difference in lymphoedema Volumetry (moderate certainty).
1 finding from 1 review
Intervention not reported
Lymphoedema ‐ short term · patients at risk for secondary upper limb lymphoedema after breast cancer treatment
It is very uncertain whether the intervention changes lymphoedema ‐ short term (very low certainty).
1 finding from 1 review
Intervention not reported
Lymphoedema ‐ medium term · patients at risk for secondary upper limb lymphoedema after breast cancer treatment
It is very uncertain whether the intervention changes lymphoedema ‐ medium term (very low certainty).
1 finding from 1 review
Intervention not reported
Shoulder range of motion for abduction ‐ short term · patients at risk for secondary upper limb lymphoedema after breast cancer treatment
1 finding from 1 review
Intervention not reported
Shoulder range of motion for forward flexion ‐ short term · patients at risk for secondary upper limb lymphoedema after breast cancer treatment
1 finding from 1 review
Intervention not reported
Shoulder range of motion for abduction ‐ medium term · patients at risk for secondary upper limb lymphoedema after breast cancer treatment
1 finding from 1 review
Intervention not reported
Shoulder range of motion for forward flexion ‐ medium term · patients at risk for secondary upper limb lymphoedema after breast cancer treatment
1 finding from 1 review
Lymphoedema ‐ medium term · patients at risk for secondary upper limb lymphoedema after breast cancer treatment
It is very uncertain whether early shoulder mobilising exercises changes lymphoedema ‐ medium term compared with delayed shoulder mobilising exercises (very low certainty).
1 finding from 1 review
Shoulder range of motion for abduction ‐ short term · patients at risk for secondary upper limb lymphoedema after breast cancer treatment
1 finding from 1 review